Use of photodynamic therapy and acitretin in generalized eruptive keratoacanthoma of Grzybowski
Author(s) -
Stephanie Mlacker,
Urvashi Kaw,
Edward V. Maytin
Publication year - 2017
Publication title -
jaad case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 16
ISSN - 2352-5126
DOI - 10.1016/j.jdcr.2017.06.013
Subject(s) - acitretin , keratoacanthoma , medicine , photodynamic therapy , dermatology , cyclophosphamide , pathology , psoriasis , chemotherapy , surgery , chemistry , basal cell , organic chemistry
Generalized eruptive keratoacanthoma of Grzybowski (GEKG), a rare variant of keratoacanthoma (KA),1 affects widespread areas of the skin and mucous membranes. First described in 1950,2 this condition is exceptionally difficult to treat. Systemic retinoids or cyclophosphamide, although sometimes effective, may not be well tolerated. We report a case of severe GEKG, unresponsive to multiple systemic agents, in which photodynamic therapy was used successfully along with acitretin for disease management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom